How Do AI Patent Review Services Actually Evaluate an AI Startup's Portfolio?

What AI Patent Review Services Actually Do

An AI patent review is a structured due-diligence exercise in which a patent attorney or specialist team reads an AI company's patent filings, maps them to the company's products, and scores their legal and commercial value. The reviewer typically checks claim scope, prosecution history, ownership chain, remaining term, and exposure to third-party rights. It is not the same as a patentability search, a freedom-to-operate opinion, or a legal opinion letter, and a reputable service will state which of those it is and is not providing. The output is usually a written report with a claim chart, a risk rating per family, and a list of gaps the company should close before an investor, acquirer, or license partner sees the portfolio. In short, AI patent review services answer the question: if this portfolio were challenged tomorrow, how much of the company's roadmap would survive?

Also worth reading: How is patent portfolio data center cooling shaping artificial intelligence infrastructure disputes? · What is international patent portfolio optimization and how can AI improve it in 2026? · What is patent portfolio management software and how do modern AI tools change intellectual property strategy?

The reason these services have grown is that AI filings are exploding. A UN report cited in the research material recorded more than 38,000 generative AI patents filed by Chinese entities between 2014 and 2023 alone, and tools like SLW Labs are now building AI into prosecution workflows. Investors have noticed, which means they will scrutinize. That scrutiny created a small professional category of AI patent review firms, from boutique practices launched recently (Fearn, for example, after raising USD $5.5 million) to in-house innovation platforms at established IP firms. Buyers of these services are usually startups preparing for a seed or Series A round, companies defending a freedom-to-operate position, and legal teams that need a fast triage of a large family list.

What a Reviewer Examines in an AI Patent

The first pass is technical and legal eligibility. Software-implemented methods face section 101 rejections in the United States under the Mayo and Alice frameworks, and a reviewer will read the issued claims to see whether they were narrowed during prosecution to a specific technical improvement rather than a generic mental process. For AI inventions, that often means checking whether the claims recite a concrete improvement to model training throughput, memory use, inference latency, or data-center scheduling rather than claiming the idea of using a neural network. A claim that survived prosecution intact is worth more than a broader claim that was allowed only after years of amendments. Reviewers also confirm that the specification supports the claims, since many startup filings have narrow written descriptions relative to their marketing claims.

The second pass covers inventorship, priority, and ownership. In February 2024 the USPTO codified its position that an inventor must be a natural person, which makes AI-generated filings without a human contributor vulnerable in the United States and echoes a wider copyright decision. Reviewers check that every named inventor is a real employee or contractor, that assignments were signed, and that university or prior-employer claims are cleared. They also verify the priority chain: a provisional gives 12 months of runway, a PCT filing opens a national-phase window of roughly 30 or 31 months from priority, and a US utility patent filed on or after 8 June 1995 lasts about 15 years from grant, not from filing. Errors here are more common than eligibility errors and more damaging, because a broken chain can void the asset entirely.

Why Investors and Buyers Care About AI Patents

Patents function as a signal, not as proof. A clean, claim-scored portfolio tells a diligence team that founders understand their own technical moat, have budget for IP, and can describe their inventions precisely enough for an examiner to grant them. The physical-AI discussion in the research material makes this point directly: founders ask whether patent filings can help them raise capital, and the honest answer is that patents do not generate revenue but they do change the quality of diligence conversations. An issued patent with narrow but relevant claims is a defensible asset; a stack of pending applications with no issued rights is a promise. Investors discount the second unless the prosecution record shows steady progress. CallRadius, for example, publicly described its advertising AI system as patent-pending, a status that reassures partners only while the application is alive and allowed.

Buyers and licensees care about a different question: can the company actually do what it claims without infringing someone else? That is freedom to operate, and no patent review substitutes for it, but a review often flags where the product overlaps a competitor's claims. The reviewer's job is to keep the two apart, because conflating them is a common source of wasted spend. Good reports state the score for each family, the jurisdictions, the maintenance status, any liens or security interests, and the encumbrances that would need to be released in a financing. Reports that omit the assignment chain are not diligence; they are marketing.

How the Review Process Usually Works

A standard engagement opens with intake: product roadmaps, founder agreements, a list of filings with application numbers, and the target jurisdiction. The reviewer then runs a prior-art and status check, often using classification systems, prosecution histories, and citation data, followed by a claim-by-claim comparison between each independent claim and the corresponding product feature. That claim chart is the heart of the work, because it shows exactly what is protected and what is not. Depending on scope, the search phase takes one to three weeks, and a full report lands in two to four weeks for a focused portfolio; a multi-jurisdiction freedom-to-operate study takes one to three months.

The final stage is scoring and recommendations. Reviewers usually rate each family as strong, acceptable, or weak based on claim breadth, prosecution concessions, remaining term, and citation density, then recommend actions such as continuing, amending through a continuation, filing in a missing market, or relying on trade secret instead. Some firms add automated scoring, and the trend is visible: SLW launched SLW Labs as an in-house platform building AI tools for patent prosecution, and South Korea has moved to compress its own review to about one month, which sets a speed expectation the private market is responding to. Buyers should ask whether the tooling is assisting attorneys or replacing them, because a purely automated score without attorney judgment understates both risk and value.

Comparison of Service Models

Each model solves a different problem, and the table is a guide rather than a ranking. A DIY review is fine for a founder with three filings who just wants to know what exists, and it is inadequate for a company with forty families across six jurisdictions. A boutique AI firm offers the best balance of speed and attorney judgment for most startups, while a large firm is justified when freedom-to-operate or a transaction is at stake. An automated platform is useful for triage, not for a decision that an investor will rely on. The right choice depends on how much is at risk, not on which tool is newest.

Common Mistakes in AI Patent Review Engagements

The first mistake is buying a patentability opinion when the goal was a diligence review. These are different questions with different deliverables, and mixing them leads to a report that says an invention is novel but says nothing about whether the current product infringes. The second mistake is letting AI-only tools produce the conclusion. Automated claim scoring can misread a dependent claim, miss a prosecution amendment, or treat a citation to old art as a fatal defect when the examiner allowed the claim anyway. The third mistake is ignoring the assignment chain and employment agreements, which is the cheapest way to lose an otherwise strong portfolio.

A fourth mistake is treating a pending application as an asset. A pending application with a first office action outstanding in 18 months is worth far less than an issued patent, and some reports quietly rate pending claims as if they were granted. A fifth mistake is filing broadly and describing narrowly. Many AI startups publish a wide abstract, file a narrow claim, and then discover that the published disclosure limits their own options, because a public disclosure can bar later patent claims in some jurisdictions. The rule of thumb is simple but often ignored: publish only after the filing strategy is settled, and file before the paper, the demo, or the investor deck goes public.

When to Act, and on What Clock

Timing matters more than most founders realize. A provisional application gives 12 months to decide whether to proceed, and waiting until month 13 forfeits that path. A PCT application typically must be filed by 12 months from priority to preserve international options, and national-phase decisions fall around 30 to 31 months. For diligence purposes, the best moment to commission a review is two to four weeks before a financing data room opens, because the report should be able to answer investor questions in real time rather than a quarter later. Acting earlier is better only if the review is likely to change what you file, not merely describe what you already filed.

There is also a case for reviewing before announcing a product. Several patent-pending announcements in the research material, including the CallRadius example, show that public claims of protection invite scrutiny. A review before launch can identify which features are actually covered, which should be kept as trade secrets, and where a competitor might sue. Waiting until after a patent-pending press release means the marketing has already set an expectation that the claims may not support. In a field moving from 2024-era music and video models to agentic AI workflows, the gap between what a company demos and what it owns is often larger than it appears.

Cost, Timelines, and What a Fair Fee Should Cover

Official USPTO filing fees for a utility application range from a few hundred dollars for micro entities to well over a thousand for large entities once search and examination fees are counted, so filing itself is not the main expense. The main expense is attorney time, and market rates for a focused portfolio review commonly fall between $3,000 and $15,000, with large-firm freedom-to-operate work reaching $50,000 and beyond. A reasonable scope should include a status and assignment check, a claim chart for at least the core independent claims, a written score, and a call to discuss findings. If the price excludes claim construction, inventorship analysis, or ownership verification, it is cheaper for a reason.

Speed expectations are rising. South Korea's move to about a one-month review, reported in 2026, and the arrival of in-house prosecution platforms show that firms are under pressure to deliver faster without lowering rigor. A one-month turnaround is plausible for a small, clean portfolio, and it is not plausible for a forty-family cross-jurisdiction study. Founders should ask what was excluded rather than only what the deadline is. A discounted one-week report that samples claims is often a triage document, and a good firm will label it as such rather than presenting it as a full opinion.

Making the Most of Your AI Patent Review

A strong report is written for two readers: the founder who must act on it and the investor who will test it. That means it should map claims to product features, flag prosecution concessions, list the countries covered, state the remaining term, and identify the two or three actions with the best return. It should also say plainly what the portfolio does not cover, because an honest gap list is more useful than a flattering score. The reviewer's credibility is measured by how many risks it names, not by how many patents it praises.

So, to return to the original question: do AI patent review services help? Yes, when you want a fast, evidence-based map of what you own, what you still need to file, and where a competitor could push back. They help most in the six to twelve months before a financing, a licensing deal, or a public launch, and they help least as a formality attached to a deck. The portfolio is not a substitute for a working product, and a bad review is worse than none, but a competent one turns a stack of application numbers into a defensible story that investors and buyers can check.